ArticleBMC public health2021
Opioid use disorder treatment disruptions during the early COVID-19 pandemic and other emergent disasters: a scoping review addressing dual public health emergencies.
Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 26 citations in OpenAlex.
- Dual Epidemics in Toronto: Shared and Divergent Neighborhood Risks of COVID-19 and Opioid Mortality from a Joint Spatial and Temporal Analysis.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- Spatial Patterns of Opioid Overdose Mortality Risk Across Urban, Transitional, and Rural Communities Using Satellite-Derived and Socioeconomic Indicators.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- Barriers to Recovery from Opioid Use Disorder Reported by Women During 2020: Insights for the Next Public Health Emergency.International journal of environmental research and public health · 2026Article
- A Mobile Health Application to Support Reductions in Overdose Risk Behaviors: A Pilot Study.Substance use & addiction journal · 2026Article
- The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysis.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025Article
- Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022.JAMA network open · 2024Article
- Challenges and Implications for Substance Use and Mental Healthcare Among Under-Resourced Women in the COVID-19 Era.Cureus · 2024Article
- "It didn't hurt me": patients' and providers' perspectives on unsupervised take-home doses, drug diversion, and overdose risks in the provision of medication for opioid use disorder during COVID-19 in San Juan, Puerto Rico.Harm reduction journal · 2024Article
- Predictors of mental health among U.S. adults during COVID-19 early pandemic, mid- pandemic, and post-vaccine eras.BMC public health · 2024Article
- Media-Based Post-Event Impact Analysis of the 2021 Heat Dome in Canada.Environmental health insights · 2024Article
- Medicare coverage of buprenorphine-naloxone film surrounding generic entry.The American journal of managed care · 2023Article
- "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.Harm reduction journal · 2023Article
- Increases in drug overdose deaths in Norway and the United States during the COVID-19 pandemic.Scandinavian journal of public health · 2023Article
- A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence.Contemporary clinical trials communications · 2022Article
- Do buprenorphine doses and ratios matter in medication assisted treatment adherence.The mental health clinician · 2022Article
- Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.International journal of environmental research and public health · 2022Article
- Changes in drug poisoning mortality before and after the COVID-19 pandemic by occupation in Massachusetts.American journal of industrial medicine · 2022Article
- COVID-19 economic impact payments and opioid overdose deaths.The International journal on drug policy · 2022Observational
- Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?The International journal on drug policy · 2022Article
- Opioids in COVID-19: Two Sides of a Coin.Frontiers in pharmacology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundDuring public health emergencies, people with opioid use disorder (PWOUD) may be particularly impacted. Emergent disasters such as the COVID-19 pandemic disrupt already-strained harm reduction efforts and treatment availability. This study aims to answer three research questions. How do public health emergencies impact PWOUD? How can health systems respond to novel public health emergencies to serve PWOUD? How can the results of this scoping review be contextualized to the province of Alberta to inform local stakeholder responses to the pandemic?
methodsWe conducted a scoping review using the 6-stage Arksey and O'Malley framework to analyse early-pandemic and pre-pandemic disaster literature. The results of the scoping review were contextualized to the local pandemic response, through a Nominal Group Technique (NGT) process with frontline providers and stakeholders in Alberta, Canada.
resultsSixty one scientific journal articles and 72 grey literature resources were included after full-text screening. Forty sources pertained to early COVID-19 responses, and 21 focused on OUD treatment during other disasters. PWOUD may be more impacted than the general population by common COVID-19 stressors including loss of income, isolation, lack of rewarding activities, housing instability, as well as fear and anxiety. They may also face unique challenges including threats to drug supplies, stigma, difficulty accessing clean substance use supplies, and closure of substance use treatment centres. All of these impacts put PWOUD at risk of negative outcomes including fatal overdose. Two NGT groups were held. One group (n = 7) represented voices from urban services, and the other (n = 4) Indigenous contexts. Stakeholders suggested that simultaneous attention to multiple crises, with adequate resources to allow attention to both social and health systems issues, can prepare a system to serve PWOUD during disasters.
conclusionThis scoping review and NGT study uncovers how disasters impact PWOUD and offers suggestions for better serving PWOUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.